Dr. Asmaa Abdelmaksoud | Molecular Pathology | Best Scholar Award
Ohio State University | United States
Dr. Asmaa Abdelmaksoud, Ph.D., is a distinguished molecular biologist and pathology researcher currently serving as a Research Associate in the Department of Ophthalmology at The Ohio State University Wexner Medical Center and a Senior Fellow in the Department of Pathology at the National Liver Institute, Menoufia University, Egypt. She holds advanced degrees in molecular biology, analytical biochemistry, and histology from Menoufia and Sadat City Universities, where she also developed expertise in molecular pathology and genetic engineering. Her professional journey reflects a strong blend of academic leadership and scientific innovation, having managed the Sustainable Science Institute Collaborative Research Centre Biobank in Egypt while mentoring graduate students and leading workshops in molecular biology and pathology. Dr. Abdelmaksoud’s research interests focus on cancer biology, hepatocellular carcinoma, genetic alterations, and molecular mechanisms underlying disease progression, supported by international training experiences in Spain, France, and the United States. Her research skills encompass histopathology, molecular diagnostics, and advanced laboratory methodologies. She has earned notable recognitions, including Best Abstract Awards from prestigious international pathology congresses for her groundbreaking work on hepatocellular carcinoma. Committed to advancing molecular diagnostics and translational medicine, Dr. Abdelmaksoud continues to contribute to global biomedical research with excellence, mentorship, and scientific integrity.
Profile: ORCID
Featured Publications
Basuni, A. A., Refat, S. A., Sawan, E., El-Abd, M. G., Abdel Maksoud, E. E., Sabri, A., Mosbeh, A., El-Hefnawy, S., Darwish, E., & Aldesoky, A. (2024). Diagnostic, prognostic, and therapeutic significance of long noncoding RNAs MALAT1 and UCA1 in hepatocellular carcinoma. Egyptian Journal of Chemistry.
Mosbeh, A., Abdelmaguid, W., Ezzat, S., Kohla, M., Sultan, M. M., & Abdel-Rahman, M. H. (2023). Low frequency of aflatoxin-induced TP53 gene codon 249 mutation in hepatocellular carcinoma from Egyptian patients living in the Nile Delta region. Asian Pacific Journal of Cancer Prevention, 24(9), 3165.
Sweed, D., Sultan, M. M., Mosbeh, A., Fayed, Y. A., Abdelsameea, E., Ehsan, N. A., Abdel-Rahman, M. H., & Waked, I. (2023). Lymphoepithelioma-like hepatocellular carcinoma: A case report and review of literature. Journal of Gastrointestinal Cancer.
Sweed, D., Abd-Elbary, A., Sweed, E., Mosbeh, A., Moaz, I., Yassein, T., & Elmashad, S. (2022). Expression of cyclo-oxygenase-2 and YAP/TAZ in hepatocellular carcinoma in untreated and treated hepatitis C virus patients. Polish Journal of Pathology.